Stem Cells Regenerative Medicine Congress is where experts like Advanced Cell Technology meet to network, learn from each other, and discuss the latest advances in regenerative medicine.

Advanced Cell Technology Shares Expertise on Advancing Toxicity and Safety Trials

Ted Myles, Chief Financial Officer and Executive Vice President of Corporate Development at Advanced Cell Technology, presented at the Stem Cells & Regenerative Medicine Congress in 2013. You can now download his presentation slides from the event, where he addresses advancing toxicity and safety trials to develop an effective macular degeneration cell-based therapy. You can view the recording of his …

Stem Cells Live: Update from ACT: AMD clinical trial progress and future directions

  A brief but informative presentation from Mathew Vincent, Advanced cell technologies (ACT) served to remind us all that their clinical trial of an embryonic stem cell based therapy for age-related macular degeneration (AMD) is ongoing and beginning to generate more long term clinical data points.   A total of 34 patients with AMD or Stargardt’s disease have been treated …

Download Presentation: Advanced Cell Technology’s Clinical Trial Progress

Gary Rabin, Chairman and CEO at Advanced Cell Technology presented on the successes and advancements of human clinical trials for the treatment of AMD & Stargardt's disease at the 2012 World Stem Cells & Regenerative Medicine Congress in London. You can freely download Gary Rabin's presentation here. The 8th Annual World Stem Cells & Regenerative Medicine Congress will return to …